Biofilm interactions shape antibiotic resistance
SUMMARY
Bacterial infections often occur in polymicrobial biofilms where nutrient limitation and interspecies interactions can profoundly shape microbial physiology. Enterococcus faecalis can antagonize Pseudomonas aeruginosa growth under conditions of iron limitation, such as those found in the mammalian host. Here, the authors report that this growth antagonism reveals surviving P. aeruginosa cells capable of surviving antibiotic challenge, including ampicillin, cefepime, and ciprofloxacin, when grown in iron-restricted biofilms with E. faecalis. Transcriptomic profiling of P. aeruginosa revealed a distinctive response characterised by broad downregulation of biosynthetic, metabolic, and virulence pathways, alongside selective induction of membrane remodeling proteins, transport systems, and biofilm-associated genes. Induction of arnT in P. aeruginosa, required for lipid A modification, correlated with enhanced antibiotic survival to ampicillin, cefepime, and ciprofloxacin. Additionally, the diguanylate cyclase SiaD and efflux transporter MfsC in P. aeruginosa were implicated in decreased antibiotic susceptibility to the same antibiotics. This transcriptional response was unique to the dual stress of iron deprivation and microbial competition with E. faecalis, illustrating how interspecies interactions can simultaneously inhibit and protect P. aeruginosa, shedding light on potential persistence mechanisms in iron-limited polymicrobial environments.This study addresses antibiotic susceptibility in Pseudomonas aeruginosa, a major opportunistic ESKAPE pathogen, within polymicrobial biofilms and under host-relevant iron-restricted conditions. Polymicrobial biofilm-associated infections are notoriously difficult to treat due to complex interspecies interactions and increased antibiotic resilience. The authors demonstrate that Enterococcus faecalis not only antagonises P. aeruginosa growth under iron limitation but also induces a unique transcriptional profile, enhancing P. aeruginosa survival during antibiotic challenge. This shift involves broad transcriptional reprogramming in P. aeruginosa, characterised by global metabolic downregulation and activation of envelope-remodelling pathways, including the arn operon. These findings reveal how interspecies interactions under iron stress can both suppress and protect bacterial pathogens and underscore the importance of considering community context in treatment strategies for persistent infections.
Full article: https://doi.org/10.1128/jb.00548-25
WHY IS THIS IMPORTANT?
Chronic infections such as wounds, urinary tract infections, and lung infections often contain multiple bacterial species living together in biofilms. In this study, researchers examined how Enterococcus faecalis influences the antibiotic susceptibility of Pseudomonas aeruginosa, an important antibiotic-resistant pathogen. Under iron-limited conditions that mimic the human body, E. faecalis strongly reduced P. aeruginosa growth. However, the remaining P. aeruginosa cells became more tolerant to several antibiotics, including commonly used β-lactams and ciprofloxacin. The study showed that the bacteria activated genes linked to membrane protection, biofilm formation, and drug efflux pumps, all of which can improve survival during antibiotic treatment. These findings suggest that bacterial competition does not always weaken pathogens; in some cases, it can push them into a protective “survival mode.” Understanding these interactions may help doctors and researchers design better therapies for persistent polymicrobial infections.
Citation:
Jeyabalan N, Tanoto FR, Antypas H, Neo CJY, Tan RJW, Pethe K, Becker DL, Stocks CJ, Kline KA.0. Enterococcus faecium colonisation and persistence in a model of diabetic wound infection. Infect Immun 0:e00652-25. https://doi.org/10.1128/iai.00652-25
Funding:
This work was funded by the Singapore Ministry of Education, the Swiss National Science Foundation and the Fondation Privée des HUG >> https://www.fondationhug.org/comment-se-joue-la-resistance-bacterienne